Zhu S - Search Results

1

Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.

Zhu S, Phatarpekar PV, Denman CJ, Senyukov VV, Somanchi SS, Nguyen-Jackson HT, Mace EM, Freeman AF, Watowich SS, Orange JS, Holland SM, Lee DA. Zhu S, et al. Blood. 2014 Jul 17;124(3):403-11. doi: 10.1182/blood-2013-05-499707. Epub 2014 Jun 2. Blood. 2014. PMID: 24891320 Free PMC article.

2

IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.

Zhu S, Lee DA, Li S. Zhu S, et al. J Immunol. 2010 Mar 1;184(5):2348-54. doi: 10.4049/jimmunol.0902371. Epub 2010 Feb 5. J Immunol. 2010. PMID: 20139275 Free PMC article.

3

Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.

Kopp LM, Ray A, Denman CJ, Senyukov VS, Somanchi SS, Zhu S, Lee DA. Kopp LM, et al. Among authors: zhu s. Mol Immunol. 2013 Jul;54(3-4):296-301. doi: 10.1016/j.molimm.2012.12.012. Epub 2013 Jan 16. Mol Immunol. 2013. PMID: 23328088

4

The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.

Zhu S, Denman CJ, Cobanoglu ZS, Kiany S, Lau CC, Gottschalk SM, Hughes DP, Kleinerman ES, Lee DA. Zhu S, et al. Pharm Res. 2015 Mar;32(3):779-92. doi: 10.1007/s11095-013-1231-0. Epub 2013 Nov 8. Pharm Res. 2015. PMID: 24203492 Free PMC article.

5

CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors.

Hu J, Zhu S, Xia X, Zhang L, Kleinerman ES, Li S. Hu J, et al. Among authors: zhu s. Mol Cancer. 2014 Feb 24;13:34. doi: 10.1186/1476-4598-13-34. Mol Cancer. 2014. PMID: 24565056 Free PMC article.

6

The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3.

Ni L, Wang L, Yao C, Ni Z, Liu F, Gong C, Zhu X, Yan X, Watowich SS, Lee DA, Zhu S. Ni L, et al. Among authors: zhu s, zhu x. Sci Rep. 2017 Mar 24;7:45266. doi: 10.1038/srep45266. Sci Rep. 2017. PMID: 28338101 Free PMC article.

7

Targeting CD155 by rediocide-A overcomes tumour immuno-resistance to natural killer cells.

Ng W, Gong C, Yan X, Si G, Fang C, Wang L, Zhu X, Xu Z, Yao C, Zhu S. Ng W, et al. Among authors: zhu s, zhu x. Pharm Biol. 2021 Dec;59(1):47-53. doi: 10.1080/13880209.2020.1865410. Pharm Biol. 2021. PMID: 33399495 Free PMC article.

8

Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis.

Zhou YF, Song SS, Tian MX, Tang Z, Wang H, Fang Y, Qu WF, Jiang XF, Tao CY, Huang R, Zhou PY, Zhu SG, Zhou J, Fan J, Liu WR, Shi YH. Zhou YF, et al. J Immunother Cancer. 2021 Aug;9(8):e003031. doi: 10.1136/jitc-2021-003031. J Immunother Cancer. 2021. PMID: 34413167 Free PMC article.

9

Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer.

Yan X, Yao C, Fang C, Han M, Gong C, Hu D, Shen W, Wang L, Li S, Zhu S. Yan X, et al. Among authors: zhu s. Int J Biol Sci. 2022 Jan 1;18(2):585-598. doi: 10.7150/ijbs.65019. eCollection 2022. Int J Biol Sci. 2022. PMID: 35002511 Free PMC article.

10

Identification of microRNA transcriptome involved in human natural killer cell activation.

Liu X, Wang Y, Sun Q, Yan J, Huang J, Zhu S, Yu J. Liu X, et al. Among authors: zhu s. Immunol Lett. 2012 Apr 30;143(2):208-17. doi: 10.1016/j.imlet.2012.02.014. Immunol Lett. 2012. PMID: 22701882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,763 results

Search Page

Filters